{"entity":{"type":"insider","cik":"0001287233","url":"/insider/0001287233","json_url":"/insider/0001287233.json","name":"SELICK HAROLD E","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":10,"first":"2007-11-26","last":"2026-03-27","span_basis":"filed_date"},"name_variants":[{"name":"SELICK HAROLD E","source":"filing","n_filings":10,"first_seen":"2007-11-26","last_seen":"2026-03-27"}],"transactions":[{"id":5781500,"accession":"0001104659-26-036318","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-036318","line_url":"/filing/0001104659-26-036318#line-2","is_derivative":false,"issuer_cik":"0001287233","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001287233","owner_cik":"0001287233","owner_name":"SELICK HAROLD E","owner_display_name":"SELICK HAROLD E","owner_url":"/insider/0001287233","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":105.0,"price_display":"105.00","price_state":"stated","total_value":2520000.0,"total_display":"2,520,000.00","total_whole":"2,520,000","shares_owned_after":60845.0,"shares_owned_after_display":"60,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-26","filed_date":"2026-03-27","scope":"insider"},{"id":2781032,"accession":"0001209191-20-018645","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-018645","line_url":"/filing/0001209191-20-018645#line-1","is_derivative":false,"issuer_cik":"0001287233","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001287233","owner_cik":"0001287233","owner_name":"SELICK HAROLD E","owner_display_name":"SELICK HAROLD E","owner_url":"/insider/0001287233","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":6.7,"price_display":"6.70","price_state":"stated","total_value":80400.0,"total_display":"80,400.00","total_whole":"80,400","shares_owned_after":15310.0,"shares_owned_after_display":"15,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-12","filed_date":"2020-03-12","scope":"insider"},{"id":7085991,"accession":"0000882104-14-000097","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000882104-14-000097","line_url":"/filing/0000882104-14-000097","is_derivative":false,"issuer_cik":"0000882104","issuer_name":"PDL BIOPHARMA, INC.","issuer_ticker":"PDLI","issuer_name_source":null,"issuer_url":"/issuer/0000882104","owner_cik":"0001287233","owner_name":"SELICK HAROLD E","owner_display_name":"SELICK HAROLD E","owner_url":"/insider/0001287233","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":8.08115,"price_display":"8.08","price_state":"stated","total_value":48486.9,"total_display":"48,486.90","total_whole":"48,487","shares_owned_after":48369.0,"shares_owned_after_display":"48,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-26","filed_date":"2014-11-28","scope":"insider","n_lines":6},{"id":9061102,"accession":"0001181431-11-018229","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-018229","line_url":"/filing/0001181431-11-018229#line-1","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":"0001287233","owner_name":"SELICK HAROLD E","owner_display_name":"SELICK HAROLD E","owner_url":"/insider/0001287233","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":47619.0,"shares_display":"47,619","price_per_share":2.1,"price_display":"2.10","price_state":"stated","total_value":99999.9,"total_display":"99,999.90","total_whole":"100,000","shares_owned_after":372321.0,"shares_owned_after_display":"372,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-11","filed_date":"2011-03-15","scope":"insider"},{"id":5821182,"accession":"0001181431-09-047065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-09-047065","line_url":"/filing/0001181431-09-047065#line-1","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":"0001287233","owner_name":"SELICK HAROLD E","owner_display_name":"SELICK HAROLD E","owner_url":"/insider/0001287233","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":52356.0,"shares_display":"52,356","price_per_share":1.86,"price_display":"1.86","price_state":"stated","total_value":97382.16,"total_display":"97,382.16","total_whole":"97,382","shares_owned_after":312670.0,"shares_owned_after_display":"312,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-05","filed_date":"2009-10-06","scope":"insider"},{"id":5678663,"accession":"0001181431-09-029127","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-029127","line_url":"/filing/0001181431-09-029127#line-2","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":"0001287233","owner_name":"SELICK HAROLD E","owner_display_name":"SELICK HAROLD E","owner_url":"/insider/0001287233","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.48,"price_display":"1.48","price_state":"stated","total_value":14800.0,"total_display":"14,800.00","total_whole":"14,800","shares_owned_after":259897.0,"shares_owned_after_display":"259,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-06-05","filed_date":"2009-06-05","scope":"insider"},{"id":5678662,"accession":"0001181431-09-029127","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-09-029127","line_url":"/filing/0001181431-09-029127#line-1","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":"0001287233","owner_name":"SELICK HAROLD E","owner_display_name":"SELICK HAROLD E","owner_url":"/insider/0001287233","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":15500.0,"total_display":"15,500.00","total_whole":"15,500","shares_owned_after":249897.0,"shares_owned_after_display":"249,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-06-03","filed_date":"2009-06-05","scope":"insider"},{"id":9250634,"accession":"0001181431-08-051708","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-08-051708","line_url":"/filing/0001181431-08-051708#line-1","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":"0001287233","owner_name":"SELICK HAROLD E","owner_display_name":"SELICK HAROLD E","owner_url":"/insider/0001287233","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":49019.0,"shares_display":"49,019","price_per_share":2.04,"price_display":"2.04","price_state":"stated","total_value":99998.76,"total_display":"99,998.76","total_whole":"99,999","shares_owned_after":239480.0,"shares_owned_after_display":"239,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-29","filed_date":"2008-09-05","scope":"insider"},{"id":2699627,"accession":"0001181431-08-051361","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-08-051361","line_url":"/filing/0001181431-08-051361#line-1","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":"0001287233","owner_name":"SELICK HAROLD E","owner_display_name":"SELICK HAROLD E","owner_url":"/insider/0001287233","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49019.0,"shares_display":"49,019","price_per_share":2.04,"price_display":"2.04","price_state":"stated","total_value":99998.76,"total_display":"99,998.76","total_whole":"99,999","shares_owned_after":239480.0,"shares_owned_after_display":"239,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-29","filed_date":"2008-09-03","scope":"insider"},{"id":7573647,"accession":"0001181431-07-072828","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-07-072828","line_url":"/filing/0001181431-07-072828#line-1","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":"0001287233","owner_name":"SELICK HAROLD E","owner_display_name":"SELICK HAROLD E","owner_url":"/insider/0001287233","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3484.0,"shares_display":"3,484","price_per_share":0.56,"price_display":"0.56","price_state":"stated","total_value":1951.04,"total_display":"1,951.04","total_whole":"1,951","shares_owned_after":1137772.0,"shares_owned_after_display":"1,137,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-29","filed_date":"2007-12-03","scope":"insider"},{"id":8217055,"accession":"0001181431-07-071659","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-07-071659","line_url":"/filing/0001181431-07-071659#line-1","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":"0001287233","owner_name":"SELICK HAROLD E","owner_display_name":"SELICK HAROLD E","owner_url":"/insider/0001287233","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":0.56,"price_display":"0.56","price_state":"stated","total_value":168.0,"total_display":"168.00","total_whole":"168","shares_owned_after":1134288.0,"shares_owned_after_display":"1,134,288","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-21","filed_date":"2007-11-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":15,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001377121","name":"Protagonist Therapeutics, Inc","url":"/issuer/0001377121","role":"Director","n_filings":2,"first_seen":"2020-03-12","last_seen":"2026-03-27"},{"type":"issuer","type_label":"ISSUER","cik":"0000882104","name":"PDL BIOPHARMA, INC.","url":"/issuer/0000882104","role":"Director","n_filings":1,"first_seen":"2014-11-28","last_seen":"2014-11-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001183765","name":"THRESHOLD PHARMACEUTICALS INC","url":"/issuer/0001183765","role":"Director, Officer (Chief Executive Officer)","n_filings":7,"first_seen":"2007-11-26","last_seen":"2011-03-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001287233","retrieved_at":"2026-08-23T05:01:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}